HR Execs on the Move

SickKids

www.sickkids.ca

 
The Hospital for Sick Children (SickKids) is recognized as one of the world’s foremost paediatric health-care institutions and is Canada’s leading centre dedicated to advancing children’s health through the integration of patient care, research and education. Founded in 1875 and affiliated with the University of Toronto, SickKids is one of Canada’s most research-intensive hospitals and has generated discoveries that have helped children globally. Our mission is to provide the best in complex and specialized family-centred care; pioneer scientific and clinical advancements; share expertise; foster an academic environment that nurtures health-care professionals; and champion an accessible, comprehensive and sustainable child ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.sickkids.ca
  • 555 University Avenue
    Toronto, ON CAN M5G 1X8
  • Phone: 416.813.1500

Executives

Name Title Contact Details

Similar Companies

MDR

MDR LLC. is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

First Choice Health

First Choice Health is a Seattle-based, physician and hospital owned company that has served Washington and the Northwest since 1985. We now serve well over one million people with our array of products and services. First Choice Health`s Preferred Provider Organization (PPO) is recognized as the leading independent PPO Network in Washington and Oregon, with a growing regional presence in Alaska, Idaho, Montana, Wyoming, and beyond. Combined our network offers over 120,000 directly contracted and credentialed providers and 369 hospitals used by a wide variety of insurance companies, third party administrators, and plan sponsors. In addition to our PPO Network, First Choice Health offers Medical Management Services, an Employee Assistance Program (EAP), a Physician Assistance Program (PAP), and Health Plan Administration (HPA).

Nava Health

Nava Health is a vertically integrated, tech-enabled healthcare practice that combines integrative, functional, preventive, and regenerative medicine to optimize health and increase longevity.

Furiex

Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.

Mauna Kea Technologies

Mauna Kea Technologies is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.